Pharmacoeconomic review report. Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
CADTH
Record ID 32014000810
English
Authors' recommendations:
Based on CDR calculations using a confidential price of $vvvvvv per milligram, the daily cost of the maximum dose of Genotropin ($vvvvvv; 0.15 mg to 1.33 mg per day) is less than that of Humatrope ($49; 0.006 mg/kg to 0.0125 mg/kg per day), Nutropin ($82; 0.042 mg/kg to 0.175 mg/kg per week), and Omnitrope ($41; 0.15 mg to 1.33 mg per day), but higher than that of Saizen ($38; 0.005 mg/kg to 0.01 mg/kg per day).
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/cdr/pharmacoeconomic/SR0332_GenotropinGHD-A_PE_Report_e.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Cost-Benefit Analysis
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.